Lupin announced that it has received an Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its manufacturing facility in Dabhasa, Gujarat.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
